FENC stock

Fennec Pharmaceuticals Inc (FENC) financials · rev $44.6M

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Fennec Pharmaceuticals Inc (FENC) rev $44.6M.

Cached annual income statement
LineFY2025FY2024
Revenue$44.6M$47.5M
Operating Income-$6.28M$2.57M
Net Income-$9.74M-$436.0K
EPS (Diluted)-$0.34-$0.02
Cached annual balance sheet
LineFY2025FY2024
Total Assets$70.6M$44.9M
Current Assets$67.0M$44.1M
Cash & Equivalents$36.8M$26.6M
Total Liabilities$35.1M$50.8M
Current Liabilities$10.5M$6.92M
Long-term DebtN/A$19.3M
Total DebtN/A$19.3M
Shareholders' Equity$35.5M-$5.87M
Retained Earnings-$229.4M-$219.7M

† Total Debt: Derived from long-term debt only (no total or short-term debt stored).

Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$12.5M$27.0M
Financing Cash Flow$22.6M-$13.6M
Net Change in Cash$10.2M$13.4M
These statements as JSON? API free 100/day

FAQ

What is FENC P/E and revenue?

Fennec Pharmaceuticals Inc (FENC) rev $44.6M.

What is FENC revenue?

Fennec Pharmaceuticals Inc last cached revenue is $44.6M (FY2025).

Is FENC profitable?

Fennec Pharmaceuticals Inc last cached net income is -$9.74M (FY2025).

What are FENC total assets?

Fennec Pharmaceuticals Inc last cached total assets are $70.6M (FY2025).

What is FENC free cash flow?

No cached cash-flow row for FENC yet.

Not investment advice. Cached statements, not a live tape.